Roku, Inc. R&D increased by 2.6% to $189.49M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.7%, from $184.58M to $189.49M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 12.1% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $113.28M | $120.31M | $126.44M | $164.00M | $196.64M | $207.61M | $220.67M | $220.09M | $192.39M | $282.20M | $183.80M | $180.46M | $175.48M | $178.80M | $185.41M | $184.58M | $178.02M | $182.24M | $184.65M | $189.49M |
| QoQ Change | — | +6.2% | +5.1% | +29.7% | +19.9% | +5.6% | +6.3% | -0.3% | -12.6% | +46.7% | -34.9% | -1.8% | -2.8% | +1.9% | +3.7% | -0.4% | -3.6% | +2.4% | +1.3% | +2.6% |
| YoY Change | — | — | — | — | +73.6% | +72.6% | +74.5% | +34.2% | -2.2% | +35.9% | -16.7% | -18.0% | -8.8% | -36.6% | +0.9% | +2.3% | +1.4% | +1.9% | -0.4% | +2.7% |